Position in MGX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$7,364
-$1,539 QoQ
Shares Held
5,496
0.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MEEDER ASSET MANAGEMENT INC holds $7,091,404 across 37 Biotechnology names. MGX ranks #28 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,094 | $4,708,465 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,424 | $1,528,950 | |
| 3 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
10,392 | $257,305 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
1,838 | $103,828 | |
| 5 | ADMA |
Adma Biologics, Inc.
|
9,759 | $87,928 | |
| 6 | VCEL |
Vericel Corp
|
1,900 | $61,123 | |
| 7 | MNPR |
Monopar Therapeutics
|
637 | $34,901 | |
| 8 | ENTA |
Enanta Pharmaceuticals Inc
|
2,025 | $25,575 |
All Filings in MGX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,364 | 5,496 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $8,903 | 5,496 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $13,025 | 5,496 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $8,134 | 5,496 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $6,968 | 5,124 | Shares | Sole | 2025-05-07 | |
| No filing history on record for this holder in this stock. | ||||||